News & Updates

Treatment with bevantolol hydrochloride (SOM3355) is well tolerated and results in a reduction in chorea among patients with Huntington’s disease (HD), a study has shown.

The use of cloxacillin alone is just as good as the combination of cloxacillin plus fosfomycin in terms of achieving treatment success among hospitalized patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia, according to the results of the open-label, phase IV-III SAFO trial presented at the ECCMID 2023.

The addition of pembrolizumab to standard chemotherapy significantly improves progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, regardless of whether they had mismatch repair-deficient (dMMR) or mismatch repair-proficient (pMMR) disease, according to the NRG-GY018 trial presented at the SGO 2023.

Treatment with the 5-HT1 receptor agonist buspirone in patients with gastroparesis falls short of reducing symptoms including moderate-to-severe early satiety/postprandial fullness, according to a study.

Women with low levels of omega-3 in early pregnancy may lower their risk of early preterm birth by taking supplements, as suggested in a study.

An antiretroviral stewardship programme led by an HIV-specialized pharmacist can improve the safety of people living with HIV (PLHIV) by reducing medication errors, as shown in a Singapore study presented at ECCMID 2023.

A linear pharmacokinetics characterizes tremelimumab, a cytotoxic T-lymphocyte-associated protein 4 human monoclonal antibody of the immunoglobulin G2 κ isotype, in patients with advanced solid tumours, reveals a study.